Adolor Corporation to Host Investor Conference Call to Report Year-End 2010 Results
February 16 2011 - 8:00AM
Business Wire
Adolor Corporation (NasdaqGM: ADLR) today announced that it will
hold a conference call at 8:30 a.m. ET on Wednesday, February 23,
2011, to discuss year-end 2010 results.
To participate in the audio portion and have the opportunity to
pose questions, dial 866-383-7989 for domestic callers or
617-597-5328 for international callers, and enter Conference ID #
15265996. Investors also can listen to the call live by logging on
to the Company’s website at www.adolor.com and clicking on
“Investor Insights,” then "Calendar of Events."
A replay of the call will be available beginning approximately
two hours after the event. To listen to a replay of the conference
call, dial 888-286-8010 (domestic) or 617-801-6888 (international)
and enter Conference ID # 55975035 or listen via Adolor’s website.
The replay will be available for one week.
About Adolor
Adolor Corporation is a biopharmaceutical company specializing
in the discovery, development and commercialization of novel
prescription pain and pain management products.
Adolor’s first approved product in the United States is ENTEREG,
which is indicated to accelerate the time to upper and lower
gastrointestinal recovery following partial large or small bowel
resection surgery with primary anastomosis. ENTEREG is available
for short-term use in hospitals registered under the E.A.S.E.®
Program. For more information on ENTEREG, including its full
prescribing information, visit www.ENTEREG.com. In collaboration
with GSK, the Company launched ENTEREG in mid-2008.
The Company's research and development pipeline includes:
ADL5945 and ADL7445, novel mu opioid receptor antagonists
undergoing clinical development for chronic OIC; and several
earlier-stage compounds under development for the management of
pain and CNS disorders.
For more information, visit www.adolor.com.
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Adolor Corp. (MM) (NASDAQ:ADLR)
Historical Stock Chart
From Jul 2023 to Jul 2024